Electra Therapeutics Employee Directory

Electra Therapeutics corporate office is located in 230 E Grand Ave Ste S100, South San Francisco, California, 94080, United States and has 11-50 employees.

Employees by Department

Departments

Number of employees

Operations

6

Medical & Health

5

Engineering & Technical

4

C-Suite

3

Sales

1

Human Resources

1

Legal

1

Key Employees of Electra Therapeutics

  • GK
    United States flag for contact location.
    Gary Koe

    Chief Technology Officer

    PhonePhoneEmailEmail
  • Kim-Hien Dao, Chief Medical Officer at Electra Therapeutics
    United States flag for contact location.
    Kim-Hien Dao

    Chief Medical Officer

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

Electra Therapeutics Global Presence

globalPresence illustration
North America11-50

Index of contact profiles from Electra Therapeutics

Hundreds of professionals searching for Electra Therapeutics have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at Electra Therapeutics

Explore people who held key positions, contributed to Electra Therapeutics's success, and advanced their careers.

People from Similar Companies in the Business Services Industry Located in California, United States

Frequently Asked Questions Regarding Electra Therapeutics Employees

How many employees does Electra Therapeutics have?
Electra Therapeutics has 11-50 employees
Who are Electra Therapeutics key employees?
Some of Electra Therapeutics key employees are Gary Koe, Kim-Hien Dao
Where is Electra Therapeutics located?
Electra Therapeutics’s headquarters are located at 230 E Grand Ave Ste S100, South San Francisco, California, 94080, United States
How do I contact Electra Therapeutics?
Electra Therapeutics Contact Info: Phone number: (888) 743-2290 Website: www.electra-therapeutics.com
What does Electra Therapeutics do?

Electra Therapeutics is a clinical stage biotechnology company pioneering therapies against novel targets for diseases in immunology and cancer. The companys lead product candidate, ELA026, is a first in class monoclonal antibody that targets signal regulatory proteins (SIRP) on immune cells to selectively deplete pathological myeloid cells and T l... ymphocytes. ELA026 is currently in pivotal development for secondary hemophagocytic lymphohistiocytosis (sHLH) and is also being evaluated in additional indications. Electra is further advancing a second SIRP-targeted program, ELA822, designed to selectively deplete activated T lymphocytes, with broad potential across immunology and inflammation (I&I).Read More

Is Electra Therapeutics a public company?
Electra Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Electra Therapeutics Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.